COVID-19 Vaccination in Patients with Hematological Malignances

COVID-19 Vaccination in Patients with Hematological Malignances

Patients with hematologic malignancies (HM) represent a population particularly vulnerable to infections due to their cancer-related immune deficiency and the immunosuppressive treatment they are administered. Accordingly, a high hospitalization and mortality rate has been consistently reported in s...

Full description

Saved in:

Bibliographic Details
Main Authors:	Massimo Franchini, Fabrizio Maggi, Daniele Focosi
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Vaccines
Subjects:	hematological malignancy SARS-CoV-2 COVID-19 vaccination mortality
Online Access:	https://www.mdpi.com/2076-393X/13/5/465
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China
by: Jun Li, et al.
Published: (2024-11-01)

Post‐COVID immunity in patients with solid tumor or hematological malignancies treated with SARS‐CoV‐2 monoclonal antibodies
by: Gilberto Sabino‐Santos, et al.
Published: (2024-12-01)

Clinical characteristics and prognosis of SARS-CoV-2 infection in children with hematological malignancies: A multicenter, retrospective study in China
by: Weilin Wang, et al.
Published: (2024-11-01)

A vaccine is not too far for COVID-19
by: Shailesh Kumar Patel, et al.
Published: (2020-05-01)

Long Term Effect of Post-Covid-19 Syndrome on Hematological Parameters in Iraqi People
by: Sara Basim Zwain, et al.
Published: (2024-06-01)

Awareness and Knowledge About Preventive Vaccinations Among Patients with Hematological Malignancies
by: Marta Morawska, et al.
Published: (2025-03-01)

Mid- and long-term mortality risk factors after COVID-19 hospitalization: A retrospective observational study in Peru
by: Max Carlos Ramírez-Soto, et al.
Published: (2025-06-01)

HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY
by: Stefano Botti, et al.
Published: (2021-01-01)

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-12-01)

A timely update of global COVID-19 vaccine development
by: Linda S. Klavinskis, et al.
Published: (2020-01-01)

Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study
by: Flavia Petrucci, et al.
Published: (2025-02-01)

Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review
by: Abby E. Rudolph, et al.
Published: (2025-12-01)

One year of COVID-19 vaccination
by: Cheng Meng-Li, et al.
Published: (2022-03-01)

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
by: Panagiotis F. Christopoulos
Published: (2021-12-01)

INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY
by: Giuseppe La Torre
Published: (2016-09-01)

COVID-19 vaccination: challenges in the pediatric population
by: Alice Nicoleta Azoicai, et al.
Published: (2025-01-01)

COVID-19 Vaccine Hesitancy Among Various Segments of the Population in Turkey: A Literature Review
by: Sezer Okay
Published: (2025-01-01)

COVID-19 and non–COVID-19 pneumonia: a comparison
by: Chiara Di Mitri, et al.
Published: (2021-01-01)

Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation
by: Eugene S. K. Lo, et al.
Published: (2025-05-01)

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective
by: Larissa Vuitika, et al.
Published: (2024-10-01)

Analysis of the primary presenting symptoms and hematological findings of COVID-19 patients in Bangladesh
by: Abu Taiub Mohammed Mohiuddin Chowdhury, et al.
Published: (2021-03-01)

Modeling the potential public health and economic impact of COVID-19 vaccination strategies using an adapted vaccine in Peru
by: Carlos Fernando Mendoza, et al.
Published: (2025-12-01)

The Benefits of COVID-19 Vaccination for Pregnant Patients Hospitalized with Respiratory Symptoms: A Retrospective Cohort Study in South Brazil
by: Christopher J. Hernandez, et al.
Published: (2024-12-01)

Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report
by: Nadia Bouhamdani, et al.
Published: (2025-06-01)

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
by: Daniele Focosi, et al.
Published: (2024-12-01)

The novel zoonotic COVID-19 pandemic: An expected global health concern
by: Carlo Contini, et al.
Published: (2020-03-01)

Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection
by: Young Hoon Hwang, et al.
Published: (2025-12-01)

Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections
by: Baha Abdalhamid, et al.
Published: (2022-04-01)

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models
by: Prajakta Warang, et al.
Published: (2025-12-01)

Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia
by: Nadine Al Akoury, et al.
Published: (2025-12-01)

Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesResearch in context
by: Darshi Shah, et al.
Published: (2025-08-01)

Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
by: Beda Islas-Muñoz, et al.
Published: (2024-02-01)

Influence of blood trace elements on immune responses and adverse symptoms subsequent to Sinopharm COVID-19 vaccination
by: Mitra Abbasifard, et al.
Published: (2024-11-01)

Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand
by: Kannikar Intawong, et al.
Published: (2023-12-01)

The Role of COVID-19 Vaccination in Serological and Infectious Response in the Xokós Indigenous Community
by: Eloia Emanuelly Dias Silva, et al.
Published: (2024-09-01)

Humoral response against COVID-19 in the population of western region of Poland
by: Dominika Siedlecka, et al.
Published: (2025-08-01)

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01)

Profile and Outcomes of COVID-19 Infection in Pediatric Patients with and without Cancer: A Case–Control Study
by: Puneet Kaur Sahi, et al.
Published: (2025-04-01)

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
by: Jesse M. van den Berg, et al.
Published: (2025-05-01)

Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study
by: Tiffany Dyu, et al.
Published: (2024-12-01)